Oriola-KD Oyj - Company Announcement

Oriola-KD signs letter of intent with four pharmacy chains in Sweden on purchasing, warehousing and pharmacy distribution of OTC products and traded goods

Oriola-KD Corporation Stock Exchange Release 9 May 2012 at 1:45 p.m.


Oriola-KD's Swedish pharmaceutical wholesale business, Oriola AB has signed a
letter of intent with Apoteksgruppen, DocMorris, Medstop and Vårdapoteket on
purchasing, warehousing and pharmacy distribution of OTC and traded goods
products. The pharmacy chains signing the letter of intent had a combined market
share of some 25 percent of the Swedish pharmacy market in 2011.(KPMG report
 01/2012)

The target is to sign co-operation agreements with the pharmacy chains during
the second quarter and to start the co-operation in the autumn of 2012."The letter of intent with Apoteksgruppen, DocMorris, Medstop and Vårdapoteket
on purchasing, warehousing and pharmacy distribution of OTC products and traded
goods is a significant strategic step for Oriola-KD. We are extremely pleased
with the upcoming co-operation with these pharmacy chains. We will continue our
determined work for providing and developing high quality services for
pharmaceutical companies and pharmacies in Sweden." Eero Hautaniemi, President &
CEO, Oriola-KD Corporation.



Oriola-KD Corporation


Eero Hautaniemi
President & CEO


For additional information, please contact:

Mr. Eero Hautaniemi
President & CEO
tel. +358 10 429 2109
email: eero.hautaniemi@oriola-kd.com

Distribution:
NASDAQ OMX Helsinki Ltd.
Principal media

Published by:
Oriola-KD Corporation
Corporate Communications
Orionintie 5
FI-02200 Espoo
www.oriola-kd.com



[HUG#1610306]